FDA Classifies Cough Drops Recall as Moderate Risk Due to Quality Concerns
The U.S. Food and Drug Administration (FDA) has classified a nationwide recall of multiple cough drop products as a Class II recall, indicating a moderate risk to consumers. The recall, initiated on March 20, 2026, was prompted by an FDA inspection at an overseas manufacturing facility that revealed conditions potentially affecting product quality. The affected products, manufactured in China by Xiamen Kang Zhongyuan Biotechnology Co., Ltd., include various flavors and are distributed under several brand names such as Exchange Select and Caring Mill. These products are sold in packages ranging from 25 to 90 counts and have expiration dates in 2026. The FDA's classification suggests that while the likelihood of serious harm is low, the use of these products may cause temporary or medically reversible adverse health effects. 
